BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang H, Zhu L, Huang C, Dong Y, Fan L, Tao L, Peng Z, Xiang R. Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis. Front Oncol 2021;11:726655. [PMID: 34660292 DOI: 10.3389/fonc.2021.726655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Huang H, Guo S, Chen YQ, Liu YX, Jin JY, Liang Y, Fan LL, Xiang R. Increased RTN3 phenocopies nonalcoholic fatty liver disease by inhibiting the AMPK-IDH2 pathway. MedComm (2020) 2023;4:e226. [PMID: 36925557 DOI: 10.1002/mco2.226] [Reference Citation Analysis]
2 Weng Y, Ning P. Construction of a prognostic prediction model for renal clear cell carcinoma combining clinical traits. Sci Rep 2023;13:3358. [PMID: 36849551 DOI: 10.1038/s41598-023-30020-4] [Reference Citation Analysis]
3 Li K, Zhu Y, Cheng J, Li A, Liu Y, Yang X, Huang H, Peng Z, Xu H. A novel lipid metabolism gene signature for clear cell renal cell carcinoma using integrated bioinformatics analysis. Front Cell Dev Biol 2023;11:1078759. [PMID: 36866272 DOI: 10.3389/fcell.2023.1078759] [Reference Citation Analysis]
4 Meng K, Hu Y, Wang D, Li Y, Shi F, Lu J, Wang Y, Cao Y, Zhang CZ, He QY. EFHD1, a novel mitochondrial regulator of tumor metastasis in clear cell renal cell carcinoma. Cancer Sci 2023. [PMID: 36747492 DOI: 10.1111/cas.15749] [Reference Citation Analysis]
5 Zhou Z, Hu F, Huang D, Chi Q, Tang NLS. Nonsense-Mediated Decay Targeted RNA (ntRNA): Proposal of a ntRNA–miRNA–lncRNA Triple Regulatory Network Usable as Biomarker of Prognostic Risk in Patients with Kidney Cancer. Genes 2022;13:1656. [DOI: 10.3390/genes13091656] [Reference Citation Analysis]
6 Huang C, Liang Y, Dong Y, Huang L, Li A, Du R, Huang H. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma. Front Cell Dev Biol 2022;10:884590. [DOI: 10.3389/fcell.2022.884590] [Reference Citation Analysis]
7 Lee M, Lee Y, Huang S, Chang C, Ko C, Lee W, Chen T, Tzou S, Huang C, Tai M, Lin Y, Kung M, Tsai M, Chen Y, Chang Y, Wen Z, Huang C, Chu T. DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis. Genes 2022;13:629. [DOI: 10.3390/genes13040629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]